Correlation Between Diamyd Medical and UMWELTBANK

Can any of the company-specific risk be diversified away by investing in both Diamyd Medical and UMWELTBANK at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diamyd Medical and UMWELTBANK into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Diamyd Medical AB and UMWELTBANK, you can compare the effects of market volatilities on Diamyd Medical and UMWELTBANK and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diamyd Medical with a short position of UMWELTBANK. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diamyd Medical and UMWELTBANK.

Diversification Opportunities for Diamyd Medical and UMWELTBANK

0.21

Correlation Coefficient

Diamyd Medical  UMWELTBANK

Modest diversification

The 3 months correlation between Diamyd and UMWELTBANK is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Diamyd Medical AB and UMWELTBANK in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UMWELTBANK and Diamyd Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diamyd Medical AB are associated (or correlated) with UMWELTBANK. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UMWELTBANK has no effect on the direction of Diamyd Medical i.e., Diamyd Medical and UMWELTBANK go up and down completely randomly.

Pair Corralation between Diamyd Medical and UMWELTBANK

Assuming the 90 days horizon Diamyd Medical AB is expected to generate 2.33 times more return on investment than UMWELTBANK. However, Diamyd Medical is 2.33 times more volatile than UMWELTBANK. It trades about 0.18 of its potential returns per unit of risk. UMWELTBANK is currently generating about -0.02 per unit of risk. If you would invest  139.00  in Diamyd Medical AB on October 25, 2024 and sell it today you would earn a total of  15.00  from holding Diamyd Medical AB or generate 10.79% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	94.44%
Values	Daily Returns

Diamyd Medical AB  vs.  UMWELTBANK

Diamyd Medical AB

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Diamyd Medical AB are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating basic indicators, Diamyd Medical reported solid returns over the last few months and may actually be approaching a breakup point.

UMWELTBANK

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in UMWELTBANK are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound forward-looking signals, UMWELTBANK is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Diamyd Medical and UMWELTBANK

The main advantage of trading using opposite Diamyd Medical and UMWELTBANK positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diamyd Medical position performs unexpectedly, UMWELTBANK can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UMWELTBANK will offset losses from the drop in UMWELTBANK's long position.

The idea behind Diamyd Medical AB and UMWELTBANK pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.